Literature DB >> 31629092

Multi-dimensional roles of ketone bodies in cancer biology: Opportunities for cancer therapy.

Siqi Feng1, Huan Wang2, Jiali Liu2, Jiye Aa2, Fang Zhou3, Guangji Wang2.   

Abstract

Ketone bodies are traditionally viewed as metabolic substrates in carbohydrate restriction and are applied in the treatment of epilepsy and other neurodegenerative diseases. Recently, people have paid more attention to its application in the treatment for cancers. Compared to normal cells, cancer cells maintain a higher level of reactive oxygen species (ROS) due to the dysfunctional oxidative phosphorylation and they highly rely on glucose for glycolysis and pentose phosphate pathway (PPP) to against the oxidative stress. Based on tumor metabolism, ketogenic diets (low-carbohydrate, high-fat, and moderate protein) or ketone supplementation, as non-toxic therapeutic approaches, showed a positive therapeutic advantage in a broad range of malignancies. This review summarizes the multi-dimensional roles of ketone bodies in cancer biology and discusses the potential underlying mechanism in the inhibition of tumor growth.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Ketone bodies; Oxidative stress; Tolerance

Year:  2019        PMID: 31629092     DOI: 10.1016/j.phrs.2019.104500

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

Review 1.  Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review.

Authors:  Hanne Mariën; Elien Derveaux; Karolien Vanhove; Peter Adriaensens; Michiel Thomeer; Liesbet Mesotten
Journal:  Metabolites       Date:  2022-06-14

Review 2.  Ketogenic Diets and Hepatocellular Carcinoma.

Authors:  Yan Lan; Chaonan Jin; Pavitra Kumar; Xia Yu; Cameron Lenahan; Jifang Sheng
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

Review 3.  Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take.

Authors:  Patricia Altea-Manzano; Alejandro M Cuadros; Lindsay A Broadfield; Sarah-Maria Fendt
Journal:  EMBO Rep       Date:  2020-09-23       Impact factor: 8.807

4.  Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients.

Authors:  Wanmeng Cui; Wenqi Luo; Xiaohui Zhou; Yunliang Lu; Wenqing Xu; Suhua Zhong; Guofei Feng; Yushan Liang; Libin Liang; Yingxi Mo; Xue Xiao; Guangwu Huang; Liudmila Matskova; Zhe Zhang; Ping Li; Xiaoying Zhou
Journal:  Front Oncol       Date:  2019-12-17       Impact factor: 6.244

5.  Identifying metabolic alterations in newly diagnosed small cell lung cancer patients.

Authors:  Shona Pedersen; Joachim Bavnhøj Hansen; Raluca Georgiana Maltesen; Weronika Maria Szejniuk; Trygve Andreassen; Ursula Falkmer; Søren Risom Kristensen
Journal:  Metabol Open       Date:  2021-09-16

6.  Effect of Ketogenic Diets on Body Composition and Metabolic Parameters of Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Haobin Zhao; Han Jin; Junfang Xian; Zhifu Zhang; Junling Shi; Xiaosu Bai
Journal:  Nutrients       Date:  2022-10-08       Impact factor: 6.706

7.  ZEB1 directly inhibits GPX4 transcription contributing to ROS accumulation in breast cancer cells.

Authors:  Xiao Han; Xianxian Duan; Zhanzhao Liu; Yaping Long; Chang Liu; Jing Zhou; Ning Li; Junfang Qin; Yue Wang
Journal:  Breast Cancer Res Treat       Date:  2021-06-24       Impact factor: 4.872

Review 8.  3-Hydroxybutyrate as a Metabolite and a Signal Molecule Regulating Processes of Living Organisms.

Authors:  Justyna Mierziak; Marta Burgberger; Wioleta Wojtasik
Journal:  Biomolecules       Date:  2021-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.